Early embryonic lethality caused by targeted disruption of the TRAF-interacting protein (TRIP) gene
- 2 October 2007
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 363 (4) , 971-977
- https://doi.org/10.1016/j.bbrc.2007.09.103
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κBNature, 2003
- CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family membersNature, 2003
- The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitinationNature, 2003
- Aspirin, ubiquitin and cancerNature, 2003
- Tumor necrosis factor receptor-associated factors (TRAFs)Oncogene, 2001
- TUMOR NECROSIS FACTOR RECEPTOR AND Fas SIGNALING MECHANISMSAnnual Review of Immunology, 1999
- TRAF6 is a signal transducer for interleukin-1Nature, 1996
- A Novel Gene Product that Couples TCR Signaling to Fas(CD95) Expression in Activation-Induced Cell DeathImmunity, 1996
- TANK, a co-inducer with TRAF2 of TNF- and CD 40L-mediated NF-kappaB activation.Genes & Development, 1996
- The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteinsCell, 1995